ArticleJournal of endocrinological investigation2017

The role of point-of-care 3-hydroxybutyrate testing in patients with type 2 diabetes undergoing coronary angiography.

S Vigili de Kreutzenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.